139 related articles for article (PubMed ID: 3267306)
1. Comparison of in vitro cloning assays for drug sensitivity testing of human brain tumours.
Berens ME; Giblin JR; Dougherty DV; Hoifodt HK; Tveit K; Rosenblum ML
Br J Neurosurg; 1988; 2(2):227-34. PubMed ID: 3267306
[TBL] [Abstract][Full Text] [Related]
2. Drug cytotoxicity at elevated temperature. In vitro study on the U-87MG glioma cell line.
Da Silva VF; Raaphorst GP; Goyal R; Feeley M
J Neurosurg; 1987 Dec; 67(6):885-8. PubMed ID: 3681426
[TBL] [Abstract][Full Text] [Related]
3. Application of in vivo and in vitro pharmacokinetics for physiologically relevant drug exposure in a human tumor clonogenic cell assay.
Ali-Osman F; Giblin J; Dougherty D; Rosenblum ML
Cancer Res; 1987 Jul; 47(14):3718-24. PubMed ID: 2954633
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, aziridinylbenzoquinone, and cis-platinum.
Schold SC; Rawlings CE; Bigner SH; Bigner DD
Neurosurgery; 1983 Jun; 12(6):672-7. PubMed ID: 6683794
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.
Paoletti P; Butti G; Knerich R; Gaetani P; Assietti R
Acta Neurochir (Wien); 1990; 103(1-2):35-46. PubMed ID: 2360465
[TBL] [Abstract][Full Text] [Related]
6. Effect of pharmacologic doses of zinc on the therapeutic index of brain tumor chemotherapy with carmustine.
Roosen N; Doz F; Yeomans KL; Dougherty DV; Rosenblum ML
Cancer Chemother Pharmacol; 1994; 34(5):385-92. PubMed ID: 7520843
[TBL] [Abstract][Full Text] [Related]
7. Prediction of human tumor cell chemosensitivity using the sister chromatid exchange assay.
Deen DF; Kendall LE; Marton LJ; Tofilon PJ
Cancer Res; 1986 Apr; 46(4 Pt 1):1599-602. PubMed ID: 3948148
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.
Tonn JC; Schönmayr R; Kraemer HP
J Neurooncol; 1990 Feb; 8(1):41-5. PubMed ID: 2319289
[TBL] [Abstract][Full Text] [Related]
9. In vitro drug sensitivity testing in human gliomas.
Kimmel DW; Shapiro JR; Shapiro WR
J Neurosurg; 1987 Feb; 66(2):161-71. PubMed ID: 3543252
[TBL] [Abstract][Full Text] [Related]
10. [Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
Aida T; Bodell WJ
No To Shinkei; 1987 Mar; 39(3):235-41. PubMed ID: 3472531
[TBL] [Abstract][Full Text] [Related]
11. An investigation of the cytotoxicity of the morpholino anthracycline MX2 against glioma cells in vitro.
Park SJ; Kaye AH; Hill JS
J Clin Neurosci; 2000 Jan; 7(1):42-7. PubMed ID: 10847650
[TBL] [Abstract][Full Text] [Related]
12. Chromosome number and carmustine sensitivity in human gliomas.
Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma.
Schold SC; Herndon JE; Burger PC; Halperin EC; Vick NA; Cairncross JG; Macdonald DR; Dropcho EJ; Morawetz R; Bigner DD
J Clin Oncol; 1993 Jan; 11(1):77-83. PubMed ID: 8418246
[TBL] [Abstract][Full Text] [Related]
14. Chemosensitivity of malignant human brain tumors. Preliminary results.
Bogdahn U
J Neurooncol; 1983; 1(2):149-66. PubMed ID: 6088712
[TBL] [Abstract][Full Text] [Related]
15. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
Slagel DE; Feola J; Houchens DP; Ovejera AA
Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
[TBL] [Abstract][Full Text] [Related]
16. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
Zhang RX; Dougherty DV; Rosenblum ML
Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells.
Khoshyomn S; Nathan D; Manske GC; Osler TM; Penar PL
J Neurooncol; 2002 May; 57(3):193-200. PubMed ID: 12125982
[TBL] [Abstract][Full Text] [Related]
18. Potential antiglioma activity of 9-hydroxy-2-N-methylellipticine as determined by pharmacological and human tumor clonogenic cell studies.
Ali-Osman F; Rosenblum ML; Giannini DD; Levin VA
Cancer Res; 1985 Jul; 45(7):2988-92. PubMed ID: 4005838
[TBL] [Abstract][Full Text] [Related]
19. Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.
Tofilon PJ; Basic I; Milas L
Cancer Res; 1985 May; 45(5):2025-30. PubMed ID: 4039220
[TBL] [Abstract][Full Text] [Related]
20. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schachenmayr W; Schönmayr R
J Neurooncol; 1992 May; 13(1):13-24. PubMed ID: 1613536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
